Stem cell therapy shows promise in treating lifelong disease By HPN Staff Key Points In a trial of 12 patients with type 1 diabetes, 10 were cured and 2 saw major improvement using the stem cell therapy Zimislecel. T... Read more Telehealth appointments can boost impact of weight-loss drugs, study finds By HPN Staff Regular telehealth appointments for obesity patients could significantly improve the effectiveness of weight-loss drugs like Ozempic and Wegovy, which are o... Read more Pharma advances non-opioid pain drugs By HPN Staff The American pharmaceutical industry has been making significant progress in developing medications that can treat severe pain as effectively as opioids without the risk of addic... Read more Feds eye tighter restrictions on pharma ads By HPN Staff The Trump administration, led by Secretary of Health and Human Services Robert F. Kennedy Jr., is considering proposals to impose restrictions on pharmaceutical advertisements. ... Read more Non-opioid pain treatment alternatives gaining public and private traction By HPN Staff In the fight to end the nation’s opioid epidemic, researchers and investors in the pain-management field are making headway in developing alternative options for treating pain. L... Read more State and local governments divvy up opioid settlement money By HPN Staff Attorneys from all 50 states have signed off on a $7.4 billion settlement with Purdue Pharma and the family that owns the company, winding down one of the largest outstanding opi... Read more Subscribe to Pharma
Telehealth appointments can boost impact of weight-loss drugs, study finds By HPN Staff Regular telehealth appointments for obesity patients could significantly improve the effectiveness of weight-loss drugs like Ozempic and Wegovy, which are o... Read more Pharma advances non-opioid pain drugs By HPN Staff The American pharmaceutical industry has been making significant progress in developing medications that can treat severe pain as effectively as opioids without the risk of addic... Read more Feds eye tighter restrictions on pharma ads By HPN Staff The Trump administration, led by Secretary of Health and Human Services Robert F. Kennedy Jr., is considering proposals to impose restrictions on pharmaceutical advertisements. ... Read more Non-opioid pain treatment alternatives gaining public and private traction By HPN Staff In the fight to end the nation’s opioid epidemic, researchers and investors in the pain-management field are making headway in developing alternative options for treating pain. L... Read more State and local governments divvy up opioid settlement money By HPN Staff Attorneys from all 50 states have signed off on a $7.4 billion settlement with Purdue Pharma and the family that owns the company, winding down one of the largest outstanding opi... Read more Subscribe to Pharma
Pharma advances non-opioid pain drugs By HPN Staff The American pharmaceutical industry has been making significant progress in developing medications that can treat severe pain as effectively as opioids without the risk of addic... Read more Feds eye tighter restrictions on pharma ads By HPN Staff The Trump administration, led by Secretary of Health and Human Services Robert F. Kennedy Jr., is considering proposals to impose restrictions on pharmaceutical advertisements. ... Read more Non-opioid pain treatment alternatives gaining public and private traction By HPN Staff In the fight to end the nation’s opioid epidemic, researchers and investors in the pain-management field are making headway in developing alternative options for treating pain. L... Read more State and local governments divvy up opioid settlement money By HPN Staff Attorneys from all 50 states have signed off on a $7.4 billion settlement with Purdue Pharma and the family that owns the company, winding down one of the largest outstanding opi... Read more Subscribe to Pharma
Feds eye tighter restrictions on pharma ads By HPN Staff The Trump administration, led by Secretary of Health and Human Services Robert F. Kennedy Jr., is considering proposals to impose restrictions on pharmaceutical advertisements. ... Read more Non-opioid pain treatment alternatives gaining public and private traction By HPN Staff In the fight to end the nation’s opioid epidemic, researchers and investors in the pain-management field are making headway in developing alternative options for treating pain. L... Read more State and local governments divvy up opioid settlement money By HPN Staff Attorneys from all 50 states have signed off on a $7.4 billion settlement with Purdue Pharma and the family that owns the company, winding down one of the largest outstanding opi... Read more Subscribe to Pharma
Non-opioid pain treatment alternatives gaining public and private traction By HPN Staff In the fight to end the nation’s opioid epidemic, researchers and investors in the pain-management field are making headway in developing alternative options for treating pain. L... Read more State and local governments divvy up opioid settlement money By HPN Staff Attorneys from all 50 states have signed off on a $7.4 billion settlement with Purdue Pharma and the family that owns the company, winding down one of the largest outstanding opi... Read more Subscribe to Pharma
State and local governments divvy up opioid settlement money By HPN Staff Attorneys from all 50 states have signed off on a $7.4 billion settlement with Purdue Pharma and the family that owns the company, winding down one of the largest outstanding opi... Read more Subscribe to Pharma
